DVAX Related Hot List
-
Dynavax Technologies (DVAX) Announces Extension of AstraZeneca (AZN), Eligible To Receive $136M
-
Dynavax Tech (DVAX) Said TOLAMBA Fails To Achieve Primary Endpoint, Discontinues Development
-
Dynavax (DVAX) and Merck (MRK) Announce FDA Places Clinical Hold on NDA's for HEPLISAV
-
Dynavax (DVAX) and Merck Announces Collaboration on HEPLISAV
-
Dynavax Tech (DVAX) Hepatitis B Vaccine Shows Statistically Significant Results
-
Dynavax (DVAX) In Collaboration with AstraZeneca for TLR-9, Could Be Worth Up to $136M
Back to DVAX Stock Lookup
